Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
Caryn Lerman Recruited By Univ. Of Pennsylvania.
BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
Impath Buys Clinical Studies Support Services Network.
MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
Vasopermeation Technology Awarded Patent For CA Firm.
FDA Approves Xeloda For Breast Cancer Treatment.
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In the Headlines: Missing record of NCAB meetings restored to NIH website
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”
